JLL names Travis McCready to grow firm's Life Sciences practice and foster connectivity across U.S. markets

Rhea-AI Summary

JLL has appointed Travis McCready as Executive Director and National Practice Leader for its Life Sciences sector. McCready will enhance JLL's strategy across the U.S., leveraging his extensive experience to drive growth in life sciences real estate. His prior roles include leadership at the Massachusetts Life Sciences Center and TMA Precision Health. The global prescription drug market is predicted to exceed $1 trillion by 2022, indicating strong demand for life sciences properties amid ongoing developments in vaccine research. This position aligns with JLL's commitment to optimizing real estate solutions in the life sciences sector.

Positive

• Appointment of Travis McCready enhances JLL's strategic focus on life sciences.
• Projected global prescription drug market exceeding $1 trillion by 2022 indicates robust growth potential.
• McCready's extensive experience is expected to drive business success in the life sciences sector.

Negative

• None.

BOSTON, Sept. 22, 2020 /PRNewswire/ -- JLL today announced Travis McCready as Executive Director and National Practice Leader in the firm's Life Sciences industry practice. McCready will focus on partnering with local market teams to intensify JLL's Life Sciences strategy across the U.S., while serving as a trusted advisor to clients and providing the full spectrum of JLL's Life Sciences real estate services.

"JLL's Industries are part of a singular ecosystem and life sciences is an integral piece of the connective tissue holding them together," said David Houck, Executive Managing Director, Industries, JLL. "Healthcare, higher education, government, and life sciences practitioners are increasingly clustering together to form innovation districts that are becoming the backbone of communities around the country. Travis will play a crucial role as a visionary, driving growth for life sciences across the nation."

With over 25 years of leadership expertise in private, public and large-scale not-for-profit institutions, McCready joins JLL from a strategic consultancy role at The Commonwealth Project, a start-up medical research and development company, as well as TMA Precision Health, where he served as an advisor for the Boston-based biomedical advisory and enterprise development company. Prior to that, McCready served as President and CEO of the Massachusetts Life Sciences Center, the economic development ­and investment agency dedicated to supporting the growth and development of life sciences in Massachusetts. Other leadership roles include The Boston Foundation, Kendall Square Association, and Harvard University.  

"Beyond COVID-19, we can expect to see robust long-term fundamentals within life sciences continuing to draw in venture capital, private equity and corporate investors, driving growth and demand for life sciences real estate," said Roger Humphrey, Division President, Industries, JLL. "Travis has a wealth of experience that will allow him to capitalize on the industry's growth and translate it into business success."

With the worldwide prescription drug market expected to surpass $1 trillion by 2022, new life sciences hubs are emerging across the nation and looking to benefit from pandemic-related tailwinds. From top-ranked Boston to rapidly expanding markets such as Seattle, McCready will help clients optimize their portfolios as they race to develop COVID-19-related vaccines. 

"There's a symbiotic relationship between commercial real estate and the ability to be successful in life sciences," said McCready. "The potential for growth in the sector is limitless and prioritizing a productive life sciences real estate strategy has the power to maximize efficiency more than ever before."

About JLL
JLL (NYSE: JLL) is a leading professional services firm that specializes in real estate and investment management. JLL shapes the future of real estate for a better world by using the most advanced technology to create rewarding opportunities, amazing spaces and sustainable real estate solutions for our clients, our people and our communities. JLL is a Fortune 500 company with annual revenue of $18.0 billion in 2019, operations in over 80 countries and a global workforce of nearly 93,000 as of June 30, 2020. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com. 

Connect with us
https://www.linkedin.com/company/jll  
https://www.facebook.com/jll  
https://twitter.com/jll  

Contact: Hannah Heilmeier
Phone: +1 715 571 2094
Email: hannah.heilmeier@am.jll.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/jll-names-travis-mccready-to-grow-firms-life-sciences-practice-and-foster-connectivity-across-us-markets-301136003.html

SOURCE JLL

FAQ

Who is Travis McCready in relation to JLL?

Travis McCready has been appointed as Executive Director and National Practice Leader in JLL's Life Sciences industry practice.

What is the significance of JLL's appointment of Travis McCready?

Travis McCready's appointment is aimed at enhancing JLL's strategy in the rapidly growing life sciences sector across the U.S.

What growth potential exists in the life sciences real estate market?

The global prescription drug market is forecasted to surpass $1 trillion by 2022, indicating significant demand for life sciences real estate.

How will McCready's role impact JLL's life sciences practice?

McCready will leverage his experience to drive growth and optimize client portfolios in life sciences, especially during vaccine development efforts.